// ICCOV埃斯克福核酸疫苗是一種預防新冠病毒去氧核醣核酸（DNA）疫苗，是醫克生物旗下PD-1增強型DNA疫苗平台首款進入第二期臨床試驗的疫苗產品。PD-1增強型DNA疫苗平台由港大愛滋病研究所發明，並向醫克生物授予專利，用以研發針對癌症及傳染病的疫苗
ICCOV, developed by EscoVale, is a DNA vaccine designed to prevent the novel coronavirus (COVID-19). It is the first vaccine product from the PD-1 Enhanced DNA Vaccine Platform, a platform developed by EscoVale’s subsidiary, Biokine. The PD-1 Enhanced DNA Vaccine Platform was invented by the AIDS Institute at the University of Hong Kong and patented by EscoVale for the development of vaccines targeting cancer and infectious diseases. http://ejtech.hkej.com/?p=135269 //